Daaz Bara Lestari Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Daaz Bara Lestari Tbk. trades at Rp1,500 (market cap 3.04T, 171.3K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Daaz Bara Lestari Tbk. is far larger — about 9.8× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 171.3K). Which is the better fit depends on your goals.
| DAAZ | DGNS | |
|---|---|---|
Market Cap | 3.04T | 310.75B |
Volume | 171.3K | 963.6K |
Lot | 1.71K | 9.64K |
Turnover | 258.66M | 217.67M |
Average Price | 1,510 | 225.89 |
Value | 258.66M | 217.67M |
Indicative Equilibrium Price | 1,500 | 226 |
Indicative Equilibrium Volume | 200 | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Daaz Bara Lestari Tbk (the Company) was established based on Notarial Deed No. 15, dated November 12, 2009, made before Iswandi, S.H., as the subtitute notary of Yulia S.H., Notary in Jakarta. The ultimate parent of the Company is PT Daaz Nusantara Abadi. The Company started commercial operations in 2019.
Read more on DAAZ →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →